Welcome!

News Feed Item

Worldwide Medical Polymer Markets: 2013-2020

NEW YORK, March 19, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Worldwide Medical Polymer Markets: 2013-2020
http://www.reportlinker.com/p01628707/Worldwide-Medical-Polymer-Markets-2013-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Plastic

SUMMARY

NanoMarkets believes that medical polymers represents a major opportunity in the medical materials market over the next few years. Several factors are leading to growth in this market. Perhaps the most obvious is the aging of the population in developed nations is expanding the addressable market for polymer implants. Many polymer implants are specifically intended to assist elder patients.
Opportunity in this market has also expanded because the latest technical developments in medical polymers can fine tune implant capabilities, enable better fits for implants, and increased biocompatibility. Polymer structures can also now substitute for cartilage or enable doctors to grow a patient's tissue for transplants.
At the same time the new legal protections that followed the silicone breast implant debacle have considerably reduced the risk in the medical polymer space. And as a result of all of these factors, the medical polymer business has taken off, with the emergence of new start ups and plenty of M&A activity.

With all that is happening in this space, NanoMarkets is publishing a report that identifies current and future opportunities in the medical polymers space and provides guidance on the technical and regulatory framework in which these opportunities are arising. As with all NanoMarkets reports in the medical materials field, this report includes a granular eight-year forecast and also profiles key suppliers and analyzes the complete supply chain for medical polymers. For the firms covered we discuss their strategies and needs along with their strengths and weaknesses. Finally, the report provides an analysis of the market for medical polymers in various important country-specific markets.

Readers of this report will gain the following:

• An analytical review of polymers used for medical applications, including developing implants, diagnostic systems, and hospital labware.
• Knowledge on current technical and market trends, including general market drivers for improvement in the healthcare sector, polymer production, and evaluation for clinical approval.
• An understanding of key medical products and their future implications.
• A pin-pointed analysis of the changing dynamics of polymer producers.
• Eight–year forecasts based on expected market growth.
• A brief technological road map for understanding industry growth.
• Profiles of major companies operating as manufacturers of medical polymers.
• Insight into important geographical locations pertaining to polymer and healthcare sectors.
• Information on the size of the medical polymer market in developed nations and the fast-growing economies in Asia, such as China and India.
• Details of the regulatory requirements of these countries for producing high-quality, medically approved polymers and their use in various applications.
• Help in making business decisions for venturing into the medical polymer market.
• Descriptive and distinctive graphics, along with concise, tabular analyses of various domains.

Executive Summary
E.1 Opportunities in the Medical Device Market
E.2 Opportunities for the Plastics Industry
E.3 Firms and Strategies to Watch in the Medical Polymer Market
E.3.1 Bayer MaterialScience
E.3.2 Celanese
E.3.3 Dow Corning
E.3.4 Dow Chemical
E.3.5 DSM
E.3.6 DuPont
E.3.7 Eastman Chemical
E.3.8 Evonik
E.3.9 Solvay
E.4 Summary of Eight-Year Forecasts of the Medical Polymer Market

Chapter One: Introduction
1.1 Background to this Report
1.1.1 Boom in Thermoplastic Elastomers (TPES) and Engineered Plastics (Super Specialty Plastics)
1.1.2 Rise of Degradable Polymers
1.1.3 Important Points for Manufacturers
1.2 Scope and Objectives of this Report
1.3 Methodology and Information Sources
1.4 Plan of this Report
Chapter Two: Commercial Trends in Medical Polymers
2.1 Generic Advantages and Disadvantages of Polymers for Medical Applications
2.1.1 Advantages of Polymers in Medical Applications
2.1.2 Disadvantages of Polymers in Medical Applications
2.1.3 Replacement of Metals with Polymers in Medical Devices
2.2 Thermoplastics (PMMA, PLA, PGA, PP, PEEK, Polycarbonates)
2.2.1 Uses of Thermoplastics in Medical Applications
2.2.2 Main Suppliers of Thermoplastics for Medical Applications
2.3 Polyethylene (PE)
2.3.1 Uses of PE in Medical Applications

2.3.2 Main Suppliers of PE for Medical Applications
2.4 Polystyrene
2.4.1 Uses of Polystyrene and Styrenics in Medical Applications
2.4.2 Main Suppliers of PS for Medical Applications
2.5 Polyvinyl Chloride
2.5.1 Uses of PVC in Medical Applications
2.5.2 Main Suppliers of PVC for Medical Applications
2.6 Nylon
2.6.1 Uses of Nylon in Medical Applications
2.6.2 Main Suppliers of Nylon for Medical Applications
2.7 Other Polymers for Medical Applications
2.8 Role of Bioplastics in Medical Applications
2.9 Key Points from this Chapter
Chapter Three: Applications for Medical Polymers
3.1 Pricing and Forecast Assumptions
3.1.1 Explanation of Polymer Pricing
3.1.2 Use of Medical Polymers in Different Applications
3.2 Medical Devices and Implants
3.2.1 Current and Future Use of Polymers
3.2.2 Regenerative Medicine and Orthopedic Implants
3.2.3 Contact Lenses and Lens Implants

3.2.4 Implantable Defibrillators and Related Devices
3.2.5 Breast Implants
3.2.6 Conductive Polymer Neural Implants
3.2.7 Blood Filters
3.2.8 Other Medical Devices Using Polymers
3.3 Eight-Year Forecast of Polymers in Implants by Polymer and Implant Type
3.4 Eight-Year Forecast of Polymers in Non-Implantable Devices by Polymer and Device Type
3.4.1 Diagnostic Systems
3.5 Eight-Year Forecast of Polymers in Diagnostic Systems by Polymer and Device Type
3.5.1 Laboratory and Surgical Accessories and Disposables
3.5.2 Surgical Screws, Nails and Plates
3.5.3 Catheters and Tubing
3.5.4 Surgical Gloves
3.5.5 Sutures and Shunts
3.6 Eight-Year Forecast of Polymers in Diagnostic Systems by Polymer and Device Type
3.7 Summary of Forecasts of Medical Polymers
3.7.1 Summary Forecast of Medical Polymers by Application
3.8 Summary Forecast of Medical Polymers by Polymer Type
3.9 Key Points in this Chapter
Chapter Four: National Markets and Regulatory Factors
4.1 Generic Policy Issues Raised by Polymer Medical Devices
4.1.1 Safety Issues Related to Polymer Devices
4.1.2 Problems of Waste Disposal and Management in Medical Polymer Manufacturing
4.1.3 Healthcare Issues and an Aging Population
4.1.4 Geographical Distribution of the Markets
4.2 The Medical Polymer Market in the United States
4.2.1 Medical Polymers and the Biomaterials Access Assurance Act of 1998
4.2.2 Impact of "Obamacare"

4.2.3 Role and Impact of the FDA
4.2.4 Analysis of the Market for Medical Polymers in the U.S.
4.2.5 Eight-Year Forecasts for Medical Polymers in the U.S.
4.3 The Medical Polymer Market in Europe
4.3.1 Role and Impact of the European Commission and Other Regulatory Authorities in the European Union
4.3.2 National Regulations and Regulatory Agencies Impacting Medical Polymer Markets in the EU
4.3.3 Analysis of the Market for Medical Polymers in Europe
4.3.4 Eight-Year Forecast for Medical Polymers in Europe
4.4 The Medical Polymer Market in Japan
4.4.1 National Laws and Regulations Impacting the Medical Polymer Market in Japan
4.4.2 Analysis of Market for Medical Polymers in Japan
4.4.3 Eight-Year Forecast for Medical Polymers in Japan
4.5 The Medical Polymer Market in China
4.5.1 National Laws and Regulations Impacting the Medical Polymer Market in China
4.5.2 Impact of Chinese Industrial Policy on the Medical Polymer Market
4.5.3 Analysis of the Market for Medical Polymers in China
4.5.4 Eight-Year Forecast for Medical Polymers in China
4.6 The Medical Polymer Market in India
4.6.1 National Laws and Regulations Impacting the Medical Polymer Market in India
4.6.2 Analysis of the Market for Medical Polymers in India
4.6.3 Eight-Year Forecast for Medical Polymers in India
4.7 Other Notable National Markets for Medical Polymers
4.7.1 The Medical Polymer Market in Canada
4.7.2 The Medical Polymer Market in Australia
4.7.3 The Medical Polymer Market in South Korea
4.8 Summary of Eight-Year Forecasts of Medical Polymers by Country
Acronyms and Abbreviations Used In this Report
About the Author

List of Exhibits

Exhibit E-1: Summary Forecast of Medical Polymers by Application ( US$ Millions)
Exhibit 2-1: Important Advantages of Polymers and Their Current Applications
Exhibit 2-2: Thermoplastics - Properties and Uses
Exhibit 2-3: Common Suppliers of Thermoplastics
Exhibit 2-4: Opportunities for Different PE Grades
Exhibit 2-5: Different Suppliers of Polyethylene Products and their Features
Exhibit 2-6: Requirements and Medical Applications for Various Types of PS
Exhibit 2-7: Suppliers Of GPPS, HIPS, and SPS Products for Medical Applications and their Trade Names
Exhibit 2-8: Suppliers and Characteristics of Flexible, Rigid and Semi-rigid Medical Grades of PVC
Exhibit 2-9: Nylon Products and Manufacturers
Exhibit 2-10: Medical Devices and Implants Made from Polyurethanes
Exhibit 2-11: Leading Teflon products, Their Manufacturers, and Application Areas
Exhibit 3-1: Pricing of Polymers and Polymer-Based Medical Products
Exhibit 3-2: Approximate Market Share of Different Polymer Types in Each Application
Exhibit 3-3: Selected Polymeric Orthopedic Products, their Manufacturers and Opportunities
Exhibit 3-4: Approved Breast Implants and their Market Opportunities
Exhibit 3-5: Overview of Important Blood Filters
Exhibit 3-6: Overview of Selected Wound Dressing Materials

Exhibit 3-7: Orthopedic Implants and Regenerative Medicines Forecast
Exhibit 3-8: Forecast of Polymer Use In Lens Implants
Exhibit 3-9: Forecast of Polymer Use in Contact Lenses
Exhibit 3-10: Forecast of Polymer Use in Implantable Defibrillators
Exhibit 3-11: Forecast of Polymer Use In Breast Implants
Exhibit 3-12: Forecast of Conductive Polymer Use In Neural Implants
Exhibit 3-13: Forecast of Polymer Use In Blood Filters
Exhibit 3-14: Forecast of Polymer Use In Other Medical Devices
Exhibit 3-15: Polymers Used in Diagnostic Devices and Their Future Opportunities
Exhibit 3-16: Forecast of Polymer Use In Diagnostic Devices
Exhibit 3-17: Forecast of Polymer Use In Automated Analyzers
Exhibit 3-18: Forecast of Polymer Use In Homecare Diagnostic Devices
Exhibit 3-19: Forecast of Polymer Use In Point-of-Care (POC) Diagnostics
Exhibit 3-20: Overview of Important Polymers for Multiple-Use and Disposable Labware Fabrication
Exhibit 3-21: Leading Labware Manufacturers and Their Brands and Market Potential
Exhibit 3-22: Selected Catheter and Tubing Products
Exhibit 3-23: Surgical Gloves and Their Specifications
Exhibit 3-24: Forecast of Polymer Use In Surgical Screws, Nails and Plates
Exhibit 3-25: Forecast of Polymer Use In Catheters and Tubing
Exhibit 3-26: Forecast of Polymer Use In Surgical Gloves
Exhibit 3-27: Forecast of Polymer Use In Sutures and Shunts
Exhibit 3-28: Summary Forecast of Medical Polymers by Application (US $Millions)
Exhibit 3-29: Summary Forecast by Top Polymer Types (U.S.$ Millions)
Exhibit 4-1: Key Industry Issues, Their Impacts, and Probable Solutions
Exhibit 4-2: Important U.S. Regulations Affecting Medical Polymers
Exhibit 4-3: Key Players in the U.S. Medical Polymer Industry Responding to Major Trends
Exhibit 4-4: Eight-Year Forecast of Medical Polymers in the U.S. (US$ Millions)
Exhibit 4-5: Key EC Regulations and Their Significance
Exhibit 4-6: Recent Technology Developments in Europe
Exhibit 4-7: Eight-Year Forecast for Medical Polymers in Europe (US$ Millions)

Exhibit 4-8: Important Regulations in Japan and Their Impact on the Medical Polymers Market
Exhibit 4-9: Recent Technology Developments in Japan
Exhibit 4-10: Eight-Year Forecast for Medical Polymers in Japan (US $Millions)
Exhibit 4-11: Key Impacts of CFDA Policies and Opportunities for Policy Improvement in China
Exhibit 4-12: Recent Technology Developments in China
Exhibit 4-13: Eight-Year Forecast for Medical Polymers in China (US $Millions)
Exhibit 4-14: Key Regulatory Impacts and Opportunities for Policy Improvement in India
Exhibit 4-15: Recent Technology Developments in India
Exhibit 4-16: Eight-Year Forecast for Medical Polymers in India (US $Millions)
Exhibit 4-17: Regulatory Scenario and Industry Opportunities in Other Markets
Exhibit 4-18: Global Eight-Year Forecast for Medical Polymers Broken Out by Country/Region

To order this report: Worldwide Medical Polymer Markets: 2013-2020
http://www.reportlinker.com/p01628707/Worldwide-Medical-Polymer-Markets-2013-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Plastic

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Blockchain. A day doesn’t seem to go by without seeing articles and discussions about the technology. According to PwC executive Seamus Cushley, approximately $1.4B has been invested in blockchain just last year. In Gartner’s recent hype cycle for emerging technologies, blockchain is approaching the peak. It is considered by Gartner as one of the ‘Key platform-enabling technologies to track.’ While there is a lot of ‘hype vs reality’ discussions going on, there is no arguing that blockchain is b...
Leading companies, from the Global Fortune 500 to the smallest companies, are adopting hybrid cloud as the path to business advantage. Hybrid cloud depends on cloud services and on-premises infrastructure working in unison. Successful implementations require new levels of data mobility, enabled by an automated and seamless flow across on-premises and cloud resources. In his general session at 21st Cloud Expo, Greg Tevis, an IBM Storage Software Technical Strategist and Customer Solution Architec...
The need for greater agility and scalability necessitated the digital transformation in the form of following equation: monolithic to microservices to serverless architecture (FaaS). To keep up with the cut-throat competition, the organisations need to update their technology stack to make software development their differentiating factor. Thus microservices architecture emerged as a potential method to provide development teams with greater flexibility and other advantages, such as the abili...
Nordstrom is transforming the way that they do business and the cloud is the key to enabling speed and hyper personalized customer experiences. In his session at 21st Cloud Expo, Ken Schow, VP of Engineering at Nordstrom, discussed some of the key learnings and common pitfalls of large enterprises moving to the cloud. This includes strategies around choosing a cloud provider(s), architecture, and lessons learned. In addition, he covered some of the best practices for structured team migration an...
Product connectivity goes hand and hand these days with increased use of personal data. New IoT devices are becoming more personalized than ever before. In his session at 22nd Cloud Expo | DXWorld Expo, Nicolas Fierro, CEO of MIMIR Blockchain Solutions, will discuss how in order to protect your data and privacy, IoT applications need to embrace Blockchain technology for a new level of product security never before seen - or needed.
The use of containers by developers -- and now increasingly IT operators -- has grown from infatuation to deep and abiding love. But as with any long-term affair, the honeymoon soon leads to needing to live well together ... and maybe even getting some relationship help along the way. And so it goes with container orchestration and automation solutions, which are rapidly emerging as the means to maintain the bliss between rapid container adoption and broad container use among multiple cloud host...
Blockchain is a shared, secure record of exchange that establishes trust, accountability and transparency across business networks. Supported by the Linux Foundation's open source, open-standards based Hyperledger Project, Blockchain has the potential to improve regulatory compliance, reduce cost as well as advance trade. Are you curious about how Blockchain is built for business? In her session at 21st Cloud Expo, René Bostic, Technical VP of the IBM Cloud Unit in North America, discussed the b...
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, discussed the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President and G.M. of US operations. Calligo is an established service provider that provides an innovative platform for trusted cloud solutions. Calligo’s customers are typically most concerned about GDPR compliance, application p...
Imagine if you will, a retail floor so densely packed with sensors that they can pick up the movements of insects scurrying across a store aisle. Or a component of a piece of factory equipment so well-instrumented that its digital twin provides resolution down to the micrometer.
ChatOps is an emerging topic that has led to the wide availability of integrations between group chat and various other tools/platforms. Currently, HipChat is an extremely powerful collaboration platform due to the various ChatOps integrations that are available. However, DevOps automation can involve orchestration and complex workflows. In his session at @DevOpsSummit at 20th Cloud Expo, Himanshu Chhetri, CTO at Addteq, will cover practical examples and use cases such as self-provisioning infra...
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settle...
The cloud era has reached the stage where it is no longer a question of whether a company should migrate, but when. Enterprises have embraced the outsourcing of where their various applications are stored and who manages them, saving significant investment along the way. Plus, the cloud has become a defining competitive edge. Companies that fail to successfully adapt risk failure. The media, of course, continues to extol the virtues of the cloud, including how easy it is to get there. Migrating...
No hype cycles or predictions of a gazillion things here. IoT is here. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, an Associate Partner of Analytics, IoT & Cybersecurity at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He also discussed the evaluation of communication standards and IoT messaging protocols, data...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
Coca-Cola’s Google powered digital signage system lays the groundwork for a more valuable connection between Coke and its customers. Digital signs pair software with high-resolution displays so that a message can be changed instantly based on what the operator wants to communicate or sell. In their Day 3 Keynote at 21st Cloud Expo, Greg Chambers, Global Group Director, Digital Innovation, Coca-Cola, and Vidya Nagarajan, a Senior Product Manager at Google, discussed how from store operations and ...